FindMyKOL

John Galla, MD

Basic profile

University of South Alabama

ORCIDNone on fileNPI↗
✓ Full record
RegionMobile, AL · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding1985–1991Why? →

John Galla is a Cardiology physician affiliated with University of South Alabama. OpenAlex indexes 29 publications with 497 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
29publications

Distinct works indexed by OpenAlex.

497citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1985–1991

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6701 Airport Blvd Ste D330
Mobile, AL 366086758

Telephone

251-607-9797

Provider last certified this registry record 16 Aug 2022.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    69.2%
    Beta blocker17.3%
    Carvedilol55%Metoprolol Succinate23%Metoprolol Tartrate9%Bisoprolol Fumarate6%Sotalol3%Nebivolol Hcl3%Acebutolol Hcl2%
    Part D<11 patients
    Statin12.5%
    Atorvastatin Calcium53%Rosuvastatin Calcium33%Pravastatin Sodium7%Simvastatin7%
    Part D<11 patients

    + 15 more classes in this area

  • Blood & clotting

    24.9%
    P2Y12 inhibitor12.1%
    Clopidogrel100%
    Part D≥160 patients
    Factor Xa inhibitor10.5%
    Xarelto51%Eliquis49%
    Part D≥52 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.5%
    Potassium supplement2.5%
    Potassium Chloride100%
    Part D≥29 patients
    Corticosteroid0.9%
    Prednisone100%
    Part D≥17 patients

    + 3 more classes in this area

Where care is delivered (Part B)11.1% facility · 88.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 1985–1991 per NIH RePORTER. The latest:

All 8 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”